Literature DB >> 23598693

Workforce analysis of neurotologists in the United States.

Jeffrey T Vrabec1.   

Abstract

OBJECTIVE: To analyze current ratio of neurotologists to the population and examine regional variation. STUDY
DESIGN: Population survey examining hospital referral regions (HRRs) as defined in the Dartmouth Atlas of Health Care Project and location of members of the American Neurotology Society. MAIN OUTCOME MEASURE: Ratio of neurotologists to the population within designated HRRs.
RESULTS: The national estimate of practicing neurotologists per population in 2006 was 1:922664 persons. The ratio is not uniform across HRRs, indicating that referral patterns for neurotologic care are wider than the care for indicators used in designating HRRs. Distribution of specialists is closely correlated with population. Estimated procedures per population are stable or declining for lateral cranial base surgery, implying current or impending oversupply of neurotologists.
CONCLUSION: The number of specialists in Neurotology likely exceeds projected needs. The current supply of trainees predicts this trend will continue for decades. Development and maintenance of lateral cranial base surgical skills will be difficult for some practitioners.

Entities:  

Mesh:

Year:  2013        PMID: 23598693     DOI: 10.1097/MAO.0b013e318280492b

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  2 in total

1.  Incidence of Intralabyrinthine Schwannoma: A Population-based Study Within the United States.

Authors:  John P Marinelli; Christine M Lohse; Matthew L Carlson
Journal:  Otol Neurotol       Date:  2018-10       Impact factor: 2.311

2.  Trends and patterns of neurotology drug prescriptions on a nationwide insurance database.

Authors:  Khodayar Goshtasbi; Mehdi Abouzari; Arash Abiri; Kasra Ziai; Brandon M Lehrich; Adwight Risbud; Soha Bayginejad; Harrison W Lin; Hamid R Djalilian
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-08-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.